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Abstract
Adenomatous polyposis coli (APC) is a multifunctional protein having diverse cellular functions including cell migra-
tion, cell-cell adhesion, cell cycle control, chromosomal segregation, and apoptosis. Recently, we found a new role
of APC in base excision repair (BER) and showed that it interacts with DNA polymerase β and 5′-flap endonuclease 1
and interferes in BER. Previously, we have also reported that cigarette smoke condensate (CSC) increases expres-
sion of APC and enhances the growth of normal human breast epithelial (MCF10A) cells in vitro. In the present
study, using APC overexpression and knockdown systems, we have examined the molecular mechanisms by which
CSC and its major component, Benzo[α]pyrene, enhances APC-mediated accumulation of abasic DNA lesions,
which is cytotoxic and mutagenic in nature, leading to enhanced neoplastic transformation of MCF10A cells in
an orthotopic xenograft model.
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Introduction
It is well accepted that cigarette smoke is a carcinogen (WHO, 2004)
and linked as a risk factor for cancer development in many organs,
including lung [1,2], head and neck [3], kidney [4,5], bladder [6],
pancreas [7], and colon [8]. However, a definitive link of cigarette
smoking with breast cancer development is not well established. In
the past several years, many epidemiological studies supported the
association of cigarette smoking and breast cancer risk. However,
there are also reports suggesting that cigarette smoking has little or
no independent effect on breast cancer risk. Recently, a Canadian
Experts Panel on tobacco smoke and breast cancer risk extensively
reviewed the research findings in this area and concluded that the
association between active smoking and breast cancer is consistent with
causality. In addition, the association between secondhand smoking
and breast cancer among younger, primarily premenopausal women
who have never smoked was consistent with causality [9]. These
conclusions were further supported by other recent findings [10–12].
Tobacco smoke contains more than 170 toxic substances, includ-
ing 33 hazardous pollutants, 47 chemicals restricted as hazardous
waste, 3 regulated air pollutants, and 67 known human or animal
carcinogens [13]. Twenty of these carcinogens, including polycyclic
aromatic hydrocarbon, benzo[α]pyrene (B[α]P), have been demon-
strated to induce mammary tumors in animal models [14]. Labora-
tory studies indicate that secondhand smoke is three to four times
more toxic than mainstream smoke [15]. The biologic possibility of
cigarette smoking and breast cancer is supported by the smoking-
specific DNA adducts and mutations in the p53 gene in the breast
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tissues of smokers [16–20]. In recent studies, we showed that cigarette
smoke condensate (CSC), a surrogate of cigarette smoke, induces expres-
sion of adenomatous polyposis coli (APC) levels, blocks base excision
repair (BER), and causes transformation of normal breast epithelial cells
in vitro [21,22]. The decreased BER is expected to increase apurinic/
apyrimidinic (AP) lesions.Whether CSC-induced APC levels are linked
with the accumulation of AP lesions and neoplastic transformation
of normal breast epithelial cells is not known. In the present study by
using an orthotopic xenograft model, we have shown a link of CSC
treatment, APC levels, and accumulation of AP lesions with CSC-
induced breast carcinogenesis.
Materials and Methods
Maintenance of Cells and Treatment
The spontaneously immortalized human normal breast epithelial cell
line MCF10A was grown at 37°C under a humidified atmosphere of
5% CO2 in Dulbecco’s modified Eagle’s medium/F-12 medium
supplemented with 5% heat inactivated horse serum (Sigma Chemical
Co, St Louis, MO), 100 U/ml penicillin, 100 μg/ml streptomycin,
0.5 μg/ml hydrocortisone, 100 ng/ml cholera toxin, 10 μg /ml insulin,
10 ng/ml epidermal growth factor, and 1% (wt/vol) of L-glutamine.
After cells reached 60% confluence, they were treated with CSC or
B[α]P as shown in the figure legends.
Preparation of CSC
CSC was prepared from the University of Kentucky Reference
Cigarette 1R4F (9 mg of tar and 0.8 mg of nicotine/cigarette) adapt-
ing the previously described procedure [23]. Briefly, the “tar” or par-
ticulate phase of smoke was collected on a Cambridge filter pad from
cigarettes smoked under standard Federal Trade Commission condi-
tions (35-ml puff volume of a 2-second duration) [24] and dissolved
in DMSO at 40 mg/ml, aliquoted into small vials, and stored frozen
at −80°C. On the day of the experiment, each vial of CSC solution
was opened and diluted in the cell culture medium to obtain the
desired concentration, vortexed vigorously, and used for the treat-
ment of cells. Control cells were treated with medium containing
an equivalent amount of DMSO.
Western Blot Analysis
For Western blot analysis, single-cell suspension of MCF10A cells
were plated (2 × 106 cells per well) in triplicates on six-well plates.
Once the cells were attached to the plates, they were transfected with
1 μg/ml pCMV-APC overexpression or pShRNA-APC knockdown
plasmids for 18 hours. After 18-hour post-transfection, one group of
cells were treated with 25 μg/ml or 50 μg/ml CSC or 25 μM or 50 μM
B[α]P for additional 30 hours. Changes in protein levels subsequent to
the treatment of MCF10A cells with CSC or B[α]P was determined by
Western blot analysis using whole-cell extracts, as described previously
[25]. The antibodies used to detect levels of APC and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were obtained from Oncogene
Research Products (Cambridge,MA) and SigmaChemical Co, respectively.
Estimation of the Number of AP Lesions in Genomic DNA
For the number of AP lesion estimation, single-cell suspension of
MCF10A cells were plated (2 × 106 cells per well) in triplicates on
six-well plates. Once the cells are attached to the bottom of the plate,
they were transfected with 1 μg/ml pCMV-APC overexpression or
pShRNA-APC plasmids for 18 hours. After 18-hour post-transfection
in one group, cells were treated with 25 μg/ml or 50 μg/ml CSC,
while cells in the other group were treated with 25 μM or 50 μM
B[α]P for additional 30 hours. For each group, appropriately control
plasmids were transfected into MCF10A cells and treated with CSC
or B[α]P. After treatment, cells were harvested and the AP lesion assay
was performed with some modification as described in previous stud-
ies [26]. Briefly, DNA from different cells (5 × 106) was isolated using
Figure 1. Effect of CSC and B[α]P treatments on the APC protein levels and the number of AP lesions in MCF10A cells. (A and C) AP lesion
estimation andWestern blot analysis of APC after treatmentwith CSC and B[α]P, respectively, for 30 hours. The protein loading is normalized
with GAPDH. (B and D) Quantitative analysis of AP lesions. Data are means ± SE of three different determinations. *Significantly different
than the untreated control group (P < .05).
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GenElute Mammalian Genomic DNA Kit (Sigma-Aldrich, St Louis,
MO). Five to 10 μg of the DNA in 150 μl of 1× phosphate-buffered
saline was incubated with 1 mM aldehyde reactive probe (Cayman
Chemicals, Ann Arbor, MI) at 37°C for 10 minutes, then ethanol pre-
cipitated and finally dissolved in 1×TE buffer (10mMTris-HCl, 1mM
EDTA, pH 7.2) and quantified. One microgram of the heat denatured
DNA was slot blotted onto a positively charged nylon membrane
(AmershamCorp, Piscataway,NJ). The nylonmembranewas soakedwith
5× SSC (0.75MNaCl, 0.075Mtrisodiumcitrate) at 37°C for 15minutes,
briefly air-dried, and baked in a vacuum oven at 80°C for 1 to 2 hours.
The membrane was preincubated with 10 ml of Tris-NaCl buffer
containing BSA [20 mM Tris-HCl (pH 7.5), 0.1 M NaCl, 1 mM
EDTA, 0.5% casein, 0.25% BSA, and 0.1% Tween 20] at room
temperature for 1 hour. The membrane was then incubated in the
same solution containing streptavidin-conjugated HRP (BioGenex,
San Ramon, CA) at room temperature for 30 to 45 minutes. The
membrane was rinsed thrice for 10 minutes each with washing buffer
(0.26MNaCl, 1 mM EDTA, 20 mMTris-HCl, and 0.1%Tween 20,
pH 7.5), and the enzymatic activity on the membrane was visualized
by the ECL Reagent (Amersham Corp). The membrane was then
exposed to X-ray film (XAR 5×; Kodak, Rochester, NY) for 5 to
10 seconds. The developed film was analyzed using an Ultrascan
XL scanning densitometer (Pharmacia, Uppsala, Sweden) and Gel
Scan XL software (Pharmacia). The quantification was based on com-
parisons to internal standard DNA containing a known amount of AP
lesions. All experiments were performed in triplicates.
Anchorage-independent Assay
The anchorage-independent growth of MCF10A cells was deter-
mined by colony formation efficiency in soft agar. Approximately
2000 MCF10A cells either transfected with pCMV-APC or pShRNA-
APC plasmids were treated with CSC or B[α]P for 30 hours. After
treatment, cells were mixed at 37°C with 2 ml of 0.33% (wt/vol)
soft agar (Sigma Chemical Co) and then poured onto a layer of pre-
viously set 1.5 ml of 0.9% soft agar (wt/vol) in six-well tissue culture
plates. The soft agar suspensions were prepared in complete Dulbecco’s
modified Eagle’s medium/F-12 medium for MCF10A cells, as
described above for the maintenance of cells. Cells were incubated
for 4 weeks, then the growth of colonies was observed under an in-
verted microscope (Zeiss Axioplan-2 Imaging, Thornwood, NY) at
×20 magnification.
Cell Proliferation Assay
We selected few clones from soft agar plates and established them in
culture. After three passages, we determined the transformation capacity
of control (MCF10A) and treated (MCF10A-CSC and MCF10A-BP)
cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay (ATCC, Manassas, VA). In principle, the viable
cell number is directly proportional to the purple formazan of the
reduced MTT dye, which can be quantitatively measured by spectro-
photometry. Briefly, 500 cells were plated onto quadruplets in 96-well
flat-bottom tissue culture plates. After 12, 24, 48, 60, or 72 hours of
incubation, 10 μl ofMTT reagent was added to eachwell and incubated
at 37°C for 4 hours to allow the formation of purple crystals of formazan.
In total, 100 μl of detergent solution was added to each well, and the
reaction mixture was incubated in dark for 2 to 4 hours (or sometimes
overnight) at room temperature. The developed color density was
then measured spectrophotometrically at 570 nm using the micro-
plate reader (Vmax Kinetic Microplate Reader from Molecular Device,
Sunnyvale, CA).
Figure 2. Effect of overexpression of APC on accumulation of AP lesions in MCF10A cells treated with CSC and B[α]P treatments. (A and
C) AP lesion estimation and Western blot analysis of APC after transient transfection of pCMV-APC for 18 hours and then treatment with
CSC and B[α]P, respectively, for additional 30 hours. The protein loading is normalized with GAPDH. (B and D) Quantitative analysis of AP
lesions. Data are means ± SE of three different determinations. *Significantly different than the untreated control group (P < .05).
#Significantly different than the control versus pCMV-APC–transfected group (P < .05).
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Orthotopic Tumor Growth and Histologic Studies
Next, to determine whether CSC- and B[α]P-induced clonogenic
growth of MCF10A cells in soft agar have acquired true transforma-
tion capacity and whether it is linked with APC expression level, we
performed in vivo experiments. We knocked down APC expression
in MCF10A cells with pShRNA-APC plasmid, as we described in our
previous studies [27]. In these studies, we used 4- to 6-week-old
athymic (nu/nu) female mice from Harlan Laboratories (Indianapolis,
Indiana). We orthotopically injected MCF10A and MCF10A-APC
(KD) cells (106), which were either untreated or treated with 10 μg/ml
CSC or 10 μM B[α]P for 30 hours. Cells were suspended in 100 μl of
50% Matrigel SQ basement membrane matrix (13.35 mg/ml; BD
Biosciences, Bedford, MA) and injected in the fourth mammary fat
pad on the right side of each mouse. The tumor growth was measured
weekly by using digital calipers. After 4 months, tumor nodules were
removed and fixed in 4% neutral buffered formalin for histologic eval-
uation with 5-μm sections stained with hematoxylin and eosin (H&E).
Statistical Analysis
All experiments were repeated at least three time and data were
expressed as means ± SE. Statistical analysis was performed using
Student’s t test. The criterion for statistical significance was P < .05.
For Western blot analysis data, band intensities were measured using
ImageJ and normalized with GAPDH.
Results
CSC and B[α]P Treatments Cause Accumulation of
AP Lesions in Normal Breast Epithelial Cells
First, we established whether the increased level of APC is linked
with the accumulation of AP lesions after treatment with CSC and
B[α]P. Results showed an increased level of APC inMCF10A cells in a
dose-dependent manner after treatment with both CSC and B[α]P
(Figure 1, A and C , respectively). To test our hypothesis that the
increased level of APC blocks BER and causes accumulation of AP
lesions, we determined the number of AP lesions in control and treated
MCF10A cells. The AP lesions increased with the increase of APC
levels after treatment with CSC and B[α]P (Figure 1, B and D, respec-
tively). Thus, the results were consistent with our hypothesis.
Overexpression of APC in MCF10A Cells Further Increases the
Number of AP Lesions after CSC and B[α]P Treatments
In these experiments, we further determined whether the increased
level of APC is linked with increased number of AP lesions. We
transfected MCF10A cells with plasmids carrying either the empty
or the pCMV-APC overexpression plasmids as described above. After
18 hours, which is sufficient to see the transient overexpression of
APC, cells were treated with different concentration of CSC (0, 25,
and 50 μg/ml) or B[α]P (0, 25, and 50 μM) for additional 30 hours.
Results showed that the treatment with CSC or B[α]P consistently
increased the level of APC and AP lesions as compared with control
(Figure 2, compare lane 1 with lane 4, respectively), which were
further increased in APC-overexpressed cells (Figure 2, compare lanes 1
to 3 with lanes 4 to 6, respectively).
Down-regulation of APC in MCF10A Cells Decreases the
Number of AP Lesions after CSC and B[α]P Treatments
To further test our hypothesis whether the increased level of APC is
associated with the increased level of AP lesions, we knocked down APC
levels in MCF10A cells by using ShRNA technique. We transfected
cells with either pShRNA-APC (pShRNA-APC) or pShRNA-APCmut
plasmids for 18 hours and then treated with different concentrations of
Figure 3. Correlation of down-regulation of APC with the accumulation of AP lesions in MCF10A cells treated with CSC and B[α]P treat-
ments. (A and C) AP lesion estimation and Western blot analysis of APC after transient transfection of pShRNA-APCmut (lanes 1–3) or
pShRNA-APC (lanes 4–6) for 18 hours and then treatment with CSC and B[α]P, respectively, for additional 30 hours. The protein loading
is normalized with GAPDH. (B and D) Quantitative analysis of AP lesions. Data are means ± SE of three different determinations. *Sig-
nificantly different than the untreated control group (P < .05).
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CSC or B[α]P for additional 30 hours. Results showed that the knock-
down of APC effectively decreased the number of AP lesions in
MCF10A cells after treatment with CSC and B[α]P (Figure 3, compare
lanes 1 to 3 and lanes 4 to 6, respectively). These results suggest that the
absence of APC enables BER system to efficiently repair AP lesions in
MCF10A cells treated with CSC and B[α]P.
Increased APC Level Is Associated with Increased Neoplastic
Transformation of MCF10A Cells Treated with
CSC and B[α]P—In Vitro Studies
To establish that the increased level of APC causes the accumula-
tion of AP lesions, which, if not repaired efficiently, can result to
neoplastic transformation of normal breast epithelial cells, we treated
MCF10A cells with CSC or B[α]P, which were either overexpressed
with pCMV-APC or knockdown with pShRNA-APC. After 30 hours
of treatment, we first performed the anchorage-independent cell
transformation assay. Results showed an increased number of trans-
formed colonies in both CSC and B[α]P-treated groups (Figure 4, A
and B, compare lane 1 with lane 2, respectively). Untreated MCF10A
cells did not form any colony. These results are consistent with our
previous findings [21]. Once the APC was overexpressed, the number
of transformed colonies were further increased after CSC and B[α]P
treatments (Figure 4, A and B, compare lane 2 with lane 4, respectively),
which then decreased after the APC level was knocked down with
pShRNA-APC (Figure 4, A and B, compare lane 4 with lane 6, respec-
tively). Furthermore, when cells were transfected with pShRNA-APCmut,
then the number of transformed colonies after CSC and B[α]P treatments
increased compared to the one transfected with pShRNA-APC plasmid
(Figure 4, A and B, compare lane 8 with lane 6, respectively). Thus, the
increased level of APC suggests a link with increased number of soft agar
colonies of MCF10A cells treated with CSC or B[α]P.
Increased APC Level Is Associated with Increased
Transformation of MCF10A Cells Treated with
CSC and B[α]P—In Vivo Studies
Next, to determine whether CSC- and B[α]P-induced clonogenic
growth of MCF10A cells in soft agar have acquired true transformation
capacity and whether it is linked with APC expression level, we per-
formed in vivo tumorigenicity experiments. For these experiments,
we orthotopically injected MCF10A and MCF10A-APC(KD) cells
(APC-knockdown cells with pShRNA-APC) into mammary pads of
female nude mice. Cells were either untreated or treated with 10 μg/ml
CSC or 10 μM B[α]P for 30 hours. Results showed that the control
MCF10A cells did not form any tumor, suggesting that they possessed
the normal epithelial cell characteristics [28]. MCF10A cells that were
treated with either CSC or B[α]P formed tumors. However, the
MCF10A cells in which the APC was knocked down did not show
any tumor formation (Figure 5A). In histologic analysis, MCF10A-
CSC and MCF10A-BP tumors showed densely packed pleomorphic
epithelial cells with numerous mitotic bodies and scattered ductular
or acinar structures. The tumors also show neovascularity in the peri-
tumoral stroma (Figure 5B). These results indicate a tumorigenic
potential of MCF10A cells after treatment with CSC, which is higher
Figure 4. Correlation of APC levels and AP lesions with neoplastic
transformation of MCF10A cells treated with CSC and B[α]P. (A and
B) Number of MCF10A-transformed colonies after CSC or B[α]P
treatment, respectively. Cells were transfected with empty vector,
pCMV-APC, pShRNA-APCmut, or pShRNA-APCplasmids as indicated
in the figure. Data are means ± SE of three different determinations.
Figure 5. Histologic analysis of tumors produced by MCF10A cells
after transformation with CSC and B[α]P treatments. (A) Size of
tumor nodules measured at the 120th day after orthotopic xenograft
implantation. (B) Histologic analysis of MCF10A-CSC and MCF10A-
BP tumors after hematoxylin and eosin staining. Data are means ±
SE of six animals in each group.
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than the treatment with B[α]P. Furthermore, these results also suggest
that the expression of APC is necessary for the transformation of
MCF10A cells to maintain the tumorigenic capacity after CSC and
B[α]P treatments.
Discussion
Results of the present study clearly provide evidence that CSC and
B[α]P treatments induce AP lesions in MCF10A cells, which are
linked with increased levels of APC. Cigarette smoke carcinogens
can be activated into electrophilic intermediates by enzymes active
in the human breast epithelial cells and the electrophilic metabolites
of tobacco carcinogens may bind to DNA and form DNA adducts.
There is evidence from the 32P-postlabeling studies that smoking-
related adducts are present in the breast tissue DNA of smokers
[29]. For example, electrophilic metabolites of B[α]P generate
DNA adducts with the nucleophilic groups of the two purine bases,
adenine and guanine [30]. It has been reported that the genomic alter-
ations observed in vitro after exposure of human breast epithelial cells to
the tobacco carcinogen, B[α]P, resemble those seen in familial breast
cancer [31]. Through comprehensive studies of the DNA adducts of
B[α]P, a strong association between depurinating adducts and onco-
genic mutations in the H-ras gene, which are generated by misrepair
rather than misreplication of the apurinic sites, is suggested as the pri-
mary culprit in tumor initiation and progression [30]. Our results are
consistent with these findings; however, we have not determined
whether it is oncogenic mutation in H-ras responsible for neoplastic
transformation of MCF10A cells after treatment with CSC or B[α]P.
The cigarette smoke also contains several DNA-alkylating agents
that form O and N alkylation products of DNA bases. These O and
N alkylation products of DNA bases are genotoxic in nature. Of
these two types of DNA alkylation products, N alkylation lesions
are predominant. The apurinic and N alkylation lesions are primarily
removed from DNA by the BER pathway. There are two different
BER pathways, i.e., short-patch (SP)–BER and long-patch (LP)–BER
[32]. Germ-line knockouts, which have a deficiency in any one of the
BER proteins, such as DNA polymerase β (Pol-β), AP endonuclease 1,
5′-flap endonuclease 1 (Fen1), or DNA ligase I, are all embryonically
lethal, indicating the importance of BER in developmental process
[33]. It has been estimated that approximately one million AP lesions
are generated per mammalian cell per day [34]. AP lesions are unstable
and degrade spontaneously into DNA strand breaks by β-elimination
that retards DNA polymerases. The AP lesions are highly mutagenic
because they result in nontemplate DNA and RNA synthesis. Despite
the large number of AP lesions generated per cell per day, the number
of mutations is extremely low because of BER, which is the main path-
way for the repair of endogenous AP lesions. So, inhibition or deficiency
of BER may result in enhanced accumulation of AP lesions that are
mutagenic and carcinogenic in nature. Recently, we found that besides
Pol-β, AP endonuclease 1, Fen1, and DNA ligase I, there is another
protein APC that has a role in the regulation of BER [35–38].
Although APC is a known tumor suppressor gene, our findings sug-
gest another role of APC that is related to DNA damage. Previously,
we have shown that APC gene expression and protein levels are
induced in cancer and normal breast and colonic epithelial cell lines
upon exposure to the DNA-alkylating agents, N -methyl-N ′-nitro-
N -nitrosoguanine, methylmethane sulfonate and dimethylhydrazine,
as well as the CSC and CSC carcinogens, dimethylbenzanthracene
and B[α]P [25,39,40]. In the present study, we overexpressed and
knocked down APC protein levels in MCF10A cells and treated them
with CSC and B[α]P. We found a positive correlation of increased
levels of APC with increased accumulation of AP lesions. Further,
we found an enhanced neoplastic transformation of MCF10A cells
in both in vitro and in vivo studies in which APC was overexpressed
and challenged with CSC or B[α]P than APC-knockdown MCF10A
cells. Our studies suggest that APC expression after DNA damage
may lose its tumor suppressor function, instead block BER and stim-
ulate carcinogenic process through accumulation of AP lesions.
In earlier studies, we have shown that the altered level of APC in
different cell lines was associated with altered activity of BER [22].
We have described that APC interacts with Pol-β and blocks Pol-β–
directed SP-BER by blocking its dRP-lyase activity [36]. We have
further shown that APC also interacts with Fen1 and blocks LP-BER
by blocking Pol-β–directed strand displacement synthesis, which is
stimulated by Fen1 [27]. The blocked SP- and LP-BER can cause
accumulation of AP lesions resulting in the transformation of target
cells. In the present study, CSC and B[α]P treatments increased the
level of APC with increased accumulation of AP lesions in mammary
epithelial cells, which might be due to Pol-β and Fen1-mediated block-
ade of BER, as discussed in our previous studies [22,27,36,37]. These
observations warrant further examination on population-based studies
to firmly establish the role of APC in DNA repair and interaction with
other mammary factors (such as hormones) with firsthand or second-
hand cigarette smoke–induced breast carcinogenesis in susceptible and
nonsusceptible populations. In addition, whether APC modulates
DNA repair capacity of breast stem cells or affects only the differentiated cells
in cigarette smoke–induced breast carcinogenesis is currently not known.
It is interesting to note that APC-knockdown MCF10A cells
formed soft agar colonies after CSC and B[α]P treatments, although
with a lesser extent than the MCF10A and APC-overexpressed
MCF10A cells (Figure 4). The CSC and B[α]P-treated APC-knockdown
MCF10A cells did not form tumors within 120 days compared
to MCF10A cells when injected into the mammary pad of nude mice
for the same period (Figure 5). This difference can be due to their acquired
tumorigenic behavior and time required for the growth of tumors. It is
possible that the 120-day time period for APC-knockdown MCF10A
cells was not sufficient for tumorigenic growth. If these cells would
have been left for additional 2 to 3 months, it is possible that we could
have seen tumorigenic growth of these cells as well. Furthermore, the
soft agar colony formation is not a true representation of the trans-
formation characteristic of a cell. In previous studies, we established
CSC-transformedMCF10A cell clones in culture. These cells made soft
agar colonies, but one of four clones grew as tumor in nude mice. The
clone that made tumor in nudemice had higher nonclonal chromosome
aberrations than others, which serves as a marker for the probability of
cancer progression [41].Whether the difference in the growth ofCSC- and
B[α]P-treated MCF10A and APC-knockdown MCF10A cells in nude
mice in the present study is due to differences in the numbers of nonclonal
chromosome aberrations is not known. Since DNA damage–induced
chromosomal aberrations are linkedwith carcinogenesis [42,43], it is likely
that APC may play a role in CSC- and B[α]P-induced chromosomal
aberrations inMCF10A cells by blocking BER and increasing AP lesions.
In any case, it appears that APC knockdown inhibits the growth of
mammary tumors after CSC and B[α]P treatments by maintaining the
increased capacity of BER and thus the decreased level of AP lesions in
these cells. In summary, we conclude that CSC and B[α]P treatments
increase the APC level, which, in turn, blocks BER resulting in the accu-
mulation of AP lesions inMCF10A cells. The accumulated AP lesions are
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mutagenic and cause neoplastic transformation of these cells. Thus, these
results provide experimental evidence that CSC, a surrogate for active or
passive (secondhand) smoking, may cause neoplastic transformation of
normal breast epithelial cells.
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